Advertisement
U.S. Markets closed

Laboratorio Reig Jofre, S.A. (RJF.MC)

MCE - MCE Delayed Price. Currency in EUR
3.0700-0.0900 (-2.85%)
At close: 05:35PM CEST

Laboratorio Reig Jofre, S.A.

Gran Capita, 10
Sant Joan Despí
Barcelona 08970
Spain
34 93 480 67 10
https://www.reigjofre.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 1,323

Key Executives

NameTitlePayExercisedYear Born
Mr. Ignasi Biosca ReigCEO & Executive Director445kN/AN/A
Ms. Roser Gomila ZabalaChief Financial OfficerN/AN/AN/A
Ms. Estefanía RuizGroup Chief Accountant & ControllerN/AN/AN/A
Ms. Victoria SerraManager of Human ResourcesN/AN/AN/A
Mr. Marc RamosHead of Tax & Financial ConsolidationN/AN/AN/A
Mr. Adolf Rousaud ViñasNon-Director SecretaryN/AN/AN/A
Amounts are as of December 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women's health; and food supplements under the Forté Pharma brand. In addition, the company provides CDMO and CMO services; and management and administration services. It sells its products through business partners. The company was founded in 1929 and is headquartered in Barcelona, Spain. Laboratorio Reig Jofre, S.A. operates as a subsidiary of Reig Jofre Investments SL.

Corporate Governance

Laboratorio Reig Jofre, S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.